<html>
<head>
<title>SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">软银愿景基金2领投数字治疗公司Biofourmis TechCrunch的1亿美元C轮融资</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2020/09/02/softbank-vision-fund-2-leads-100-million-series-c-in-digital-therapeutics-company-biofourmis/amp/">https://web.archive.org/web/https://techcrunch.com/2020/09/02/softbank-vision-fund-2-leads-100-million-series-c-in-digital-therapeutics-company-biofourmis/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="A publicity photo of patients using digital therapeutics startup Biofourmis' Biovitals system" srcset="https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png 5360w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=150,100 150w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=300,200 300w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=768,512 768w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=680,453 680w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=1536,1024 1536w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=2048,1366 2048w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=1200,800 1200w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=50,33 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/b6554fbf78bc78530b14b7f9ed3f0018.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="A publicity photo of patients using digital therapeutics startup Biofourmis' Biovitals system" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png 5360w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=150,100 150w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=300,200 300w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=768,512 768w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=680,453 680w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=1536,1024 1536w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=2048,1366 2048w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=1200,800 1200w, https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?resize=50,33 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20230128055611im_/https://techcrunch.com/wp-content/uploads/2020/09/BiovitalsHF_Patient-App.png?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong> <a href="https://web.archive.org/web/20230128055611/https://www.biofourmis.com/" target="_blank">生物博览会</a></p><p class="translated"><a href="https://web.archive.org/web/20230128055611/https://www.biofourmis.com/" target="_blank" rel="noopener noreferrer"> Biofourmis </a>，结合基于人工智能的数据分析和生物传感器来监测医疗治疗的进展，已经从世界上最知名的投资者之一那里筹集了资金。这家在新加坡成立、总部位于波士顿的数字治疗公司今天宣布，完成了由软银愿景基金2号(SoftBank Vision Fund 2)领投的1亿美元C轮融资，回归投资者Openspace Ventures、MassMutual Ventures、红杉资本和EDBI也参与了投资。</p>
<p class="translated">该公司上一次宣布融资是在2019年5月，由红杉印度和马萨诸塞州相互人寿保险公司的风险投资部门MassMutual牵头的<a href="https://web.archive.org/web/20230128055611/https://techcrunch.com/2019/05/21/biofourmis-raises-35m/">3500万美元B轮</a>。迄今为止，该公司已经筹集了总计1.45亿美元的资金。</p>
<p class="translated">Biofourmis的平台结合了基于人工智能的健康分析和可穿戴传感器，以帮助医疗保健提供商衡量患者的进展以及药物和其他治疗的有效性。该公司于2015年由首席执行官库尔迪普·辛格·拉吉普特(Kuldeep Singh Rajput)和董事总经理文都·牛(Michael Niu)创立，表示这是迄今为止东南亚健康科技初创公司的最大一笔资金。除了波士顿和新加坡，Biofourmis还在瑞士和印度设有办事处。</p>
<p class="translated">自B轮融资以来，Biofourmis通过与7家制药公司和10个卫生系统的一系列合作而发展壮大，其中包括诺华、阿斯利康和梅奥诊所。Biofourmis还进行了几次收购，包括可穿戴生物传感器初创公司Biovotion和癌症患者数字治疗公司Gaido Health。</p>
<p class="translated">这笔资金将用于验证和向市场推出心脏病学、呼吸系统、肿瘤学和疼痛治疗的新数字治疗解决方案。Biofourmis计划在美国和亚太市场扩张，包括中国和日本。</p>
<p class="translated">Biofourmis今天还表示，它正在重新调整其内部运营，分为两个垂直领域:Biofourmis Therapeutics，它与阿斯利康和Chugai等公司合作，开发可以帮助提高药物治疗效果的软件，以及Biofourmis Health，这是一个“家庭医院”平台，允许医疗服务提供商在病人脱离急性护理时远程监控他们。Biofourmis Health专注于心力衰竭、冠状动脉疾病、呼吸系统疾病和癌症。</p>
<p class="translated">EDBI是一家与新加坡政府有关联的投资公司，它寻找能够帮助推动新加坡工业发展的初创公司，包括医疗保健行业。Biofourmis来自EDBI的资金是一项战略投资，它的技术被用于新加坡应对新冠肺炎病毒的反复爆发。</p>
<p class="translated">去年7月，软银愿景基金2 <a href="https://web.archive.org/web/20230128055611/https://techcrunch.com/2019/07/25/softbank-announces-ai-focused-second-108-billion-vision-fund-with-lps-including-microsoft-apple-and-foxconn/">宣布启动1080亿美元</a>投资人工智能技术。第一个愿景基金<a href="https://web.archive.org/web/20230128055611/https://techcrunch.com/2020/05/18/the-first-vision-fund-is-officially-done-investing-and-spent-100m-every-day-of-its-existence/">正在应对很大程度上源于其在WeWork和优步投资的重大损失</a>，因此愿景基金2对包括健康技术在内的市场的关注(它在该领域的其他投资包括<a href="https://web.archive.org/web/20230128055611/https://www.businessinsider.com/exclusive-softbank-leads-latest-alto-pharmacy-funding-round-at-over-1-billion-valuation-2020-1">医药交付初创公司Alto </a>和<a href="https://web.archive.org/web/20230128055611/https://kariusdx.com/about/news/karius-secures-165-million-series-b-funding-led-softbank-vision-fund-2">生命科学公司Karius </a>)的表现受到密切关注<a href="https://web.archive.org/web/20230128055611/https://www.cnbc.com/2020/05/22/softbanks-vision-fund-ii-in-jeopardy.html"/>。</p>
<p class="translated">在一份新闻声明中，软银投资顾问合伙人格雷格·穆恩说:“我们相信预测健康是医学的未来，Biofourmis是利用人工智能和基于机器学习的模型推进数字治疗的领导者。”</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20230128055611im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20230128055611im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=2039401&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>